.svg){kind=small}
The AHA Scientific Sessions 2022 are a gathering of scientific and clinical professionals with the aim of cardiovascular health improvement through global education.
The research undertaken by Dr Jorg Taubel et al. will be presented during the conference: First-in-Human in vivo CRISPR/Cas9 Editing of the TTR Gene by NTLA-2001 in Patients with Transthyretin Amyloidosis with Cardiomyopathy
The topics presented at the AHA Scientific Sessions 2022 are advocating scientific discovery, clinical practise and more with global speakers, sessions on digital health, leadership education for healthcare leaders and more.
To find out more AHA 2022 Registration | AHA Scientific Sessions 2022
-min.jpg)
.jpg)
Latest news
Richmond Appoints Lisa Campbell as Director of Regulatory Strategy
April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read moreVon Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol
April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read moreEvents
Swiss Biotech Day 2025
5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event
